Federal prosecutors have charged Texas physician Jason Finkelstein with healthcare fraud and conspiracy, alleging he orchestrated an $89 million scheme that billed insurers for unnecessary cardiovascular screenings of college athletes. According to the U.S. Department of Justice, Finkelstein routinely certified test results as “normal” without reviewing them, leading to undetected cardiac issues in patients and at least one documented fatality.
How the $89 Million Fraud Scheme Operated
The scheme, which spanned from 2019 through late 2024, relied on a two-pronged strategy involving deceptive marketing and fraudulent billing. Prosecutors allege that Finkelstein and two unidentified co-conspirators utilized a Florida-based testing practice to offer “free” heart screenings to student-athletes. According to the indictment, the group emailed athletic trainers at various universities, claiming the tests could identify life-threatening conditions. To bypass insurance requirements for medical necessity, the indictment states that Finkelstein submitted phony diagnoses—including hypertension and elevated blood pressure—for students who did not actually have those conditions.
The indictment alleges that Finkelstein was aware of the risks, once telling a co-conspirator, “These kids could be high risk… One of them drops dead on a field, they’re coming after both of us.”
What Are the Risks of Unverified Cardiovascular Screening?
The primary danger in this case stemmed from the lack of professional oversight. According to the Justice Department, Finkelstein employed sonographers who lacked the requisite credentials to perform the exams. Furthermore, the indictment details a specific 2024 incident where Finkelstein allegedly signed off on approximately 63 test images for a single patient in just 11 seconds. The patient, who possessed multiple undiagnosed cardiac abnormalities, subsequently died. Dr. Mehmet Oz, head of the Centers for Medicare & Medicaid Services, characterized the conduct as “heinous,” noting that the fraud moved beyond financial theft to endanger human lives.
Future Trends in Healthcare Fraud Enforcement
This prosecution signals a shift toward aggressive federal oversight of mobile diagnostic services. While previous enforcement efforts often focused on billing for services never rendered, the Justice Department is increasingly prioritizing “poor medical performance” that results in patient harm. This case aligns with a broader nationwide crackdown on healthcare fraud, a priority that has gained significant momentum under the current administration. Industry observers suggest that insurers may soon implement stricter credentialing requirements for third-party diagnostic providers to prevent similar “rubber-stamping” schemes.
Always verify that any cardiovascular screening provider is credentialed by the American Registry for Diagnostic Medical Sonography (ARDMS) or a similar accredited body before allowing testing on school or club sports campuses.
Frequently Asked Questions
What is the status of the legal proceedings against Jason Finkelstein?
Finkelstein appeared in a Florida court on Monday and entered a plea of not guilty. His legal counsel has not yet provided a public statement regarding the specific allegations.
How were the fraudulent claims submitted to insurance companies?
Because Finkelstein held medical licenses in 48 contiguous states, he was able to submit claims for patients across the country. He allegedly falsified medical histories to manufacture a “medical necessity” that insurance providers require for coverage.
What should student-athletes look for to avoid fraudulent testing?
Legitimate cardiac screenings should always be performed by licensed sonographers and reviewed by a board-certified cardiologist who provides a detailed report. Be wary of “free” screenings that do not involve a direct consultation with a physician.
Have you or a family member encountered questionable medical screening practices? Share your experiences in the comments below or subscribe to our newsletter for the latest updates on healthcare consumer protection.
